United States · FDA National Drug Code directory
Hydromorphone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0641-2341_29e3211f-1115-45e9-8416-c3dfe01a9916
- Product NDC
- 0641-2341
- Form
- INJECTION
- Composition / generic term
- Hydromorphone Hydrochloride
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 19720101
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROMORPHONE HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 20 VIAL in 1 CARTON (0641-2341-41) / 20 mL in 1 VIAL (0641-2341-39) · 0641-2341-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →